Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug;42(8):1453-1460.
doi: 10.1007/s00296-022-05114-3. Epub 2022 Apr 19.

Orbital myositis in systemic lupus erythematosus: a case-based review

Voulgari V Paraskevi  1 , Venetsanopoulou I Aliki  2 , Pieta Antigone  2 , Tziortzioti Zoi  2 , Zikou K Anastasia  3 , Drosos A Alexandros  2
Affiliations
Review

Orbital myositis in systemic lupus erythematosus: a case-based review

Voulgari V Paraskevi et al. Rheumatol Int. 2022 Aug.

Abstract

Ocular complications occur in up to one-third of patients with systemic lupus erythematosus (SLE). Among them, orbital myositis (OM) is considered a rare manifestation that affects the extraocular muscles and causes pain and restriction with eye movement. We report a case of OM in a 48-year-old female with SLE and secondary Sjogren's Syndrome, who presented headache, periorbital edema, and painful ocular movements in both eyes, with no other systemic manifestations. An orbital magnetic resonance image revealed thickening of the right medial rectus and left lateral rectus muscles. Laboratory tests were normal and there was no further disease activity. The patient was treated with prednisone 1 mg/Kg/day with a resolution of symptoms. We found 13 additional cases of OM from our literature review (11 SLE patients and 2 with discoid lupus erythematosus). There was a female predominance in these cases with a mean age of 43.6 years (SD ± 16.9). Their main clinical features included eye pain, swelling, proptosis, diplopia, and limitations in extraocular muscles, while in most of them, there was no other active systemic manifestation. Treatment with steroids led to the complete resolution of symptoms in most of these patients. The available evidence suggests that it is essential to have a high index of suspicion for OM in SLE patients even when there is no systemic disease activity so that proper treatment is initiated early.

Keywords: Orbital myositis; Systemic lupus erythematosus.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Dammacco R (2018) Systemic lupus erythematosus and ocular involvement: an overview. Clin Exp Med 18:135–149. https://doi.org/10.1007/s10238-017-0479-9 - DOI - PubMed
    1. Silpa-archa S, Lee JJ, Stephen Foster C (2016) Ocular manifestations in systemic lupus erythematosus. Br J Ophthalmol 100:135–141. https://doi.org/10.1136/bjophthalmol-2015-306629 - DOI - PubMed
    1. Theodoridou A, Settas L (2006) Demyelination in rheumatic diseases. J Neurol Neurosurg Psychiatry 77:290–295. https://doi.org/10.1136/jnnp.2005.075861 - DOI - PubMed - PMC
    1. Jabs DA, Miller NR, Newman SA, Johnson MA, Stevens MB (1986) Optic neuropathy in systemic lupus erythematosus. Arch Ophthalmol 104:564–568. https://doi.org/10.1001/archopht.1986.01050160120026 - DOI - PubMed
    1. Giorgi D, BalaccoGabrieli C (1999) Optic neuropathy in systemic lupus erythematosus and antiphospholipid syndrome (APS): clinical features, pathogenesis, review of the literature and proposed ophthalmological criteria for APS diagnosis. Clin Rheumatol 18:124–131. https://doi.org/10.1007/s100670050069 - DOI - PubMed

LinkOut - more resources